Related references
Note: Only part of the references are listed.Recent advances in antigen processing and presentation
Peter E. Jensen
NATURE IMMUNOLOGY (2007)
A lymphocytic choriomeningitis virus glycoprotein variant that is retained in the endoplasmic reticulum efficiently cross-primes CD8+ T cell responses
Stefan Freigang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Decreased tumor surveillance after adoptive T cell therapy
Matthias Matter et al.
CANCER RESEARCH (2007)
Monoclonal antibodies targeted against melanoma and ovarian tumors enhance dendritic cell-mediated cross-presentation of tumor-associated antigens and efficiently cross-prime CD8(+) T cells
DP Cioca et al.
JOURNAL OF IMMUNOTHERAPY (2006)
Enhancement of dendritic cell antigen cross-presentation by CpG DNA involves type IIFN and stabilization of class I MHC mRNA
J Kuchtey et al.
JOURNAL OF IMMUNOLOGY (2005)
Inefficient cross-presentation limits the CD8+ T cell response to a subdominant tumor antigen epitope
P Otahal et al.
JOURNAL OF IMMUNOLOGY (2005)
Cross-presentation of the long-lived lymphocytic choriomeningitis virus nucleoprotein does not require neosynthesis and is enhanced via heat shock proteins
S Basta et al.
JOURNAL OF IMMUNOLOGY (2005)
Efficient cross-priming of tumor antigen-specific T cells by dendritic cells sensitized with diverse anti-MICA opsonized tumor cells
V Groh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Increased immunogenicity of an anchor-modified tumor-associated antigen is due to the enhanced stability of the peptide/MHC complex: Implications for vaccine design
OY Borbulevych et al.
JOURNAL OF IMMUNOLOGY (2005)
Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen delivery
M Schnurr et al.
BLOOD (2005)
Cross-presentation by intercellular peptide transfer through gap junctions
J Neijssen et al.
NATURE (2005)
A listing of human tumor antigens recognized by T cells: March 2004 update
L Novellino et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Cellular protein is the source of cross-priming antigen in vivo
LJ Shen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Bystander elimination of antigen loss variants in established tumors
MT Spiotto et al.
NATURE MEDICINE (2004)
Activation of dendritic cells that cross-present tumor-derived antigen licenses CD8+ CTL to cause tumor eradication
GJD van Mierlo et al.
JOURNAL OF IMMUNOLOGY (2004)
Cross-priming of CD8(+) T cells by viral and tumor antigens is a robust phenomenon
WS Chen et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens
WR Heath et al.
IMMUNOLOGICAL REVIEWS (2004)
CD8+T cell cross-priming via transfer of proteasome substrates
CC Norbury et al.
SCIENCE (2004)
Antigen bias in T cell cross-priming
MC Wolkers et al.
SCIENCE (2004)
Immunodominance of an antiviral cytotoxic T cell response is shaped by the kinetics of viral protein expression
HC Probst et al.
JOURNAL OF IMMUNOLOGY (2003)
Feedback regulation of pathogen-specific T cell priming
P Wong et al.
IMMUNITY (2003)
Epitope dominance, competition and T cell affinity maturation
RM Kedl et al.
CURRENT OPINION IN IMMUNOLOGY (2003)
Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma:: In vivo persistence, migration, and antitumor effect of transferred T cells
C Yee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Increasing tumor antigen expression overcomes ignorance to solid tumors via crosspresentation by bone marrow-derived stromal cells
MT Spiotto et al.
IMMUNITY (2002)
Direct priming and cross-priming contribute differentially to the induction of CD8+ CTL following exposure to vaccinia virus via different routes
XF Shen et al.
JOURNAL OF IMMUNOLOGY (2002)
The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo
T Iyoda et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
CD40 stimulation leads to effective therapy of CD40-tumors through induction of strong systemic cytotoxic T lymphocyte immunity
GJD van Mierlo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Estimating the precursor frequency of naive antigen-specific CD8 T cells
JN Blattman et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Redundancy of direct priming and cross-priming in tumor-specific CD8+ T cell responses
MC Wolkers et al.
JOURNAL OF IMMUNOLOGY (2001)
Cross-presentation of tumor antigens by bone marrow-derived antigen-presenting cells is the dominant mechanism in the induction of T-cell tolerance during B-cell lymphoma progression
EM Sotomayor et al.
BLOOD (2001)
Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction
AF Ochsenbein et al.
NATURE (2001)
Recombinant expression of lymphocytic choriomeningitis virus strain WE glycoproteins: a single amino acid makes the difference
WR Beyer et al.
JOURNAL OF VIROLOGY (2001)
CD8+ T cell-dependent elimination of dendritic cells in vivo limits the induction of antitumor immunity
IF Hermans et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
